| Literature DB >> 27305384 |
Vito Coviello1, Beatrice Marchi1, Stefania Sartini1, Luca Quattrini1, Anna Maria Marini1, Francesca Simorini1, Sabrina Taliani1, Silvia Salerno1, Paola Orlandi2, Anna Fioravanti2, Teresa Di Desidero2, Daniela Vullo3, Federico Da Settimo1, Claudiu T Supuran4, Guido Bocci2, Concettina La Motta1.
Abstract
Three novel series of 1,2-benzisothiazole derivatives have been developed as inhibitors of carbonic anhydrase isoform IX. Compounds 5c and 5j, tested in vitro on the human colon cell line HT-29, blocked the growth of cells cultured under chemically induced hypoxic conditions, displaying a specific activity against cancer cells characterized by CAIX up-regulation. Moreover, a synergistic activity of 5c with SN-38 (the active metabolite of irinotecan) and 5-fluorouracil on cell proliferation under hypoxic conditions was demonstrated.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27305384 DOI: 10.1021/acs.jmedchem.6b00616
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446